Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02946619 · ClinicalTrials.gov registry record · NA
Health Benefits of Expressive Writing Among Chinese Breast Cancer Survivors
A NA study, sponsored by University of Houston.
- Completed
- Registry status
- NA
- Development phase
- 136
- Enrollment target
NCT02946619: Completed NA study, sponsored by University of Houston.
NCT02946619 is a NA study that has completed, run by University of Houston. The registered enrollment target is 136 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02946619, a NA study, has completed, sponsored by University of Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 136 participants
- Enrollment target
Study Summary
This study is a randomized controlled trial (RCT) with the aim of determining the cultural sensitivity, feasibility, and effectiveness of an expressive writing intervention for Chinese breast cancer survivors.
Primary Outcome
The Functional Assessment of Cancer Therapy Scale (FACT) is a 27-item measure of health-related quality of life (Cella \& Tulsky,1993), which assesses perceived life quality in four different facets, including physical well-being (7 items,score range 0 - 28), social well-being (7 items, score range 0 - 28), emotional well-being (6 items, score range 0-24), and functional well-being (7 items, score range 0-28). A higher subscale score indicates better functioning in the corresponding domain. Tot
Interventions
- BEHAVIORAL Self-Regulation Condition
- BEHAVIORAL Enhanced self-Regulation Condition
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2012-06 |
| Est. Completion | 2016-03 |
| Phase | NA |
What the finished NCT02946619 record still lists
NCT02946619 is an interventional study that assigns participants to a tested intervention. The registered 136 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 2 interventions - of which Self-Regulation Condition is the first listed.
NCT02946619 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02946619 about?
NCT02946619 is a clinical study titled "Health Benefits of Expressive Writing Among Chinese Breast Cancer Survivors". This study is a randomized controlled trial (RCT) with the aim of determining the cultural sensitivity, feasibility, and effectiveness of an expressive writing intervention for Chinese breast cancer survivors.
What is the current status of trial NCT02946619?
This trial is currently completed. It is a NA study. The enrollment target is 136 participants. The study started on 2012-06. Estimated completion is 2016-03.
What interventions are being tested in trial NCT02946619?
The interventions under investigation include: Self-Regulation Condition (BEHAVIORAL), Enhanced self-Regulation Condition (BEHAVIORAL).
Who is sponsoring clinical trial NCT02946619?
This trial is sponsored by University of Houston, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02946619's enrollment target sits among peer trials
136 722nd of 2000 higher than 1,275 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01555892 · 136 participants · Phase 1
Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE
- NCT03216525 · 136 participants · Phase 3
Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol
- NCT04476901 · 136 participants · Phase 2
Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy
- NCT04603898 · 136 participants · NA
Oxalate Formation From Ascorbic Acid
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia